Ciclesonide
- Generic Name
- Ciclesonide
- Brand Names
- Alvesco, Omnaris, Zetonna
- Drug Type
- Small Molecule
- Chemical Formula
- C32H44O7
- CAS Number
- 126544-47-6
- Unique Ingredient Identifier
- S59502J185
- Background
Ciclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.
- Indication
For the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older.
- Associated Conditions
- Asthma, Bronchoconstriction, Chronic Obstructive Pulmonary Disease (COPD), Perennial Allergic Rhinitis (PAR), Seasonal Allergic Rhinitis
- Associated Therapies
- -
Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2013-04-30
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 327
- Registration Number
- NCT01401465
- Locations
- 🇺🇸
The Clinical Research Center, L.L.C., St. Louis, Missouri, United States
🇺🇸Clinical Research Institute of Southern Oregon, PC, Medford, Oregon, United States
🇺🇸Pharmacuetical Research & Consulting, Inc., Dallas, Texas, United States
Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma
- First Posted Date
- 2011-04-12
- Last Posted Date
- 2011-04-12
- Lead Sponsor
- Grünenthal Colombiana S.A.
- Target Recruit Count
- 94
- Registration Number
- NCT01333800
- Locations
- 🇨🇴
Hospital San Rafael, Bogotá, Colombia
Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma
- First Posted Date
- 2010-11-25
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 408
- Registration Number
- NCT01248065
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center/Stroger Hospital, Chicago, Illinois, United States
🇺🇸University of Illinois at Chicago, Chicago, Illinois, United States
Small Particle Steroids in Refractory Asthma
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2014-01-31
- Lead Sponsor
- University of Nottingham
- Target Recruit Count
- 30
- Registration Number
- NCT01171365
- Locations
- 🇬🇧
University Hospitals of Leicester NHS Trust, Leicester, Leicestershire, United Kingdom
🇬🇧Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom
ATEM (Alvesco Non-interventional Study)
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 400
- Registration Number
- NCT01147224
- Locations
- 🇦🇹
Nycomed Pharma GmbH, Zwettl, Austria
Ciclesonide for the Treatment of Airway Hyperresponsiveness
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 64
- Registration Number
- NCT00826969
- Locations
- 🇨🇭
Nycomed, Basel, Switzerland
Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)
- Conditions
- Interventions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 420
- Registration Number
- NCT00659503
- Locations
- 🇨🇦
Altana/Nycomed, Kingston, Ontario, Canada
Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2016-12-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 106
- Registration Number
- NCT00659048
- Locations
- 🇺🇸
Altana/Nycomed, San Antonio, Texas, United States
Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)
- Conditions
- Interventions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 500
- Registration Number
- NCT00659594
- Locations
- 🇨🇦
Altana/Nycomed, Mississauga, Ontario, Canada
To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 418
- Registration Number
- NCT00659750
- Locations
- 🇺🇸
Altana/Nycomed, Madison, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.